Billets de Michelle Dawson

Billet publié sur Bluesky le 02/06/2026 11:34

Bluesky Publication avec DOI crossref Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

"Irritability in autistic adults is a major crisis"? "what is labeled 'irritability' in many autistic adults may often be a physiological response to cumulative stress or trauma, or a manifestation of intrinsic neurobiological dysregulation..."? onlinelibrary.wiley.com/doi/10.1002/... review, free

Voir sur Bluesky

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Hsiang‐Yuan Lin, Arthur N. Westover, Amy S. F. Lutz, Manish K. Jha (2026). Beyond the Outburst: Charting a New Frontier for Understanding and Treating Irritability in Autistic Adults. Autism Research, e70287. Wiley.

Date de publication
01/06/2026
Identifiant
10.1002/aur.70287
Auteurs
Hsiang‐Yuan Lin, Arthur N. Westover, Amy S. F. Lutz, Manish K. Jha
Source
Autism Research
Détails
e70287
Type de référence
article
Éditeur
Wiley
Source de métadonnées
crossref

Résumé

ABSTRACT Irritability is a prevalent and impairing feature associated with autism, yet remains poorly understood, particularly in adults. Drawing heavily on insights translated from pediatric and transdiagnostic literatures, we propose that irritability in autistic individuals often reflects a psychophysiological stress or threat response, rooted in a vulnerable neurobiology (e.g., sensory sensitivities, intolerance of uncertainty), but may also stem from intrinsic neurobiological dysregulation independent of environmental triggers. The current treatment paradigm for autistic adults, largely extrapolated from pediatric antipsychotic trials, leaves these adults critically underserved due to a lack of evidence‐based treatments, clinical trials, or validated tools to measure their internal experience. This viewpoint deconstructs irritability, differentiating its affective nature from aggression, and highlights heterogeneity across the lifespan and support needs. We critique the limitations of current assessment methods and recommend a shift toward a multi‐modal strategy integrating self‐report (when feasible) with objective, physiologically‐informed tools (e.g., wearable biosensors) and nuanced observer reports. We argue that the field is poised for neuroscience‐informed treatment innovation—including novel pharmacological agents and adapted psychosocial interventions—but is hampered by a lack of rigorous clinical trials in adults. Finally, we call for mechanistically driven trials to address the large unmet burden of inadequately treated irritability, ultimately improving the quality of life for autistic adults and their families/caregivers.

Auteur·ices de l’étude dans cette référence citée